Academic literature on the topic 'Outside consultant'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Outside consultant.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Outside consultant"
1
Spurrell, Mark. "Consultant learning groups in psychiatry." Psychiatric Bulletin 24, no. 10 (2000): 390–92. http://dx.doi.org/10.1192/pb.24.10.390.
Full textAbstract:
There is growing emphasis on the importance of continuing professional development (CPD) for consultant psychiatrists and an increasing recognition of the need for peer support. In this context the Royal College of Psychiatrists has been developing policy around CPD; a policy document has been issued by The College Council (Royal College of Psychiatrists, 1994) and there are regular updates on this topic on the website (www.rcpsych.ac.uk). All consultants are to be expected to take part in CPD and currently the annual requirement is for 20 hours of ‘external’ CPD and 30 hours of ‘internal’ CPD. ‘External’ refers to didactic or workshop events that involve input from outside a clinician's locality; ‘internal’ refers to local activities, case conferences, journal clubs, etc. CPD follows a 5-year rolling cycle, supported by the journal Advances in Psychiatric Treatment, a recommended 2 hours per week personal study and the development of personal development plans. From the outset there appear to have been issues in engaging consultants in CPD (Morgan, 1998). The problems of establishing CPD extend beyond consultants ‘finding the time’.
2
Tucker, William, Mark Olfson, Steven Simring, William Goodman, and Scott Bienenfeld. "A Pilot Survey of Inmate Preferences for On-Site, Visiting Consultant, and Telemedicine Psychiatric Services." CNS Spectrums 11, no. 10 (2006): 783–87. http://dx.doi.org/10.1017/s1092852900014905.
Full textAbstract:
ABSTRACTObjectiveTo assess inmate preferences for in-prison mental health services, outside psychiatric consultants, and telemedicine psychiatric consultation for 16 mental health services.MethodsStructured interviews were conducted of the service modality preferences of 28 inmates who received psychiatric telemedicine consultations in NewYork State Department of Corrections facilities.ResultsFor five of the 16 mental health services assessed, a significantly larger proportion of inmates preferred delivery of mental services by their on-site mental health team to an outside psychiatric consultant, whether visiting or using telemedicine. For another eight services, inmate preferences were approximately equal. For three services (treatment progress, evaluation of childhood sexual abuse, and sexual concerns), inmates reported a trend toward preference for out-side consultation (visiting and telemedicine combined). For no service did inmates prefer telemedicine to a visiting consultant.ConclusionAlthough inmates prefer the use of on-site mental health professionals for many mental health services, some inmates prefer visiting or telemedicine consultants for the evaluation of safety and sexual issues. Because telemedicine is efficient and readily available, its role in these areas requires further evaluation.
3
Murdoch, Jane M., and John M. Eagles. "‘Stress-busting’ groups for consultant psychiatrists." Psychiatric Bulletin 31, no. 4 (2007): 128–31. http://dx.doi.org/10.1192/pb.bp.106.010934.
Full textAbstract:
Aims and MethodTo describe the formation and function of ‘stress-busting’ groups and report a survey on work-related stress among a small cohort of consultant psychiatrists.ResultsOf 37 questionnaires, 25 were returned and 16 respondents (64%) rated their overall level of stress at work as moderate or severe. Stressful factors included lack of staff, paperwork, high-risk patients, difficult/hostile relatives and job demands interfering with family life. The most helpful stress-reducing strategies were talking to colleagues for support and catharsis, outside interests, support from family and friends, effective time management and exercise. Among 15 current members of ‘stress-busting’ groups, 14 (93%) found these to be helpful. The most successful format in the ‘stress-busting’ groups was one of ‘problem-solving with ventilation of stresses'.Clinical Implications‘Stress-busting’ groups may constitute a helpful approach to work-related stress and a utilisation of the skills of psychiatrists to our mutual benefit.
4
Courvoisier, D., K. Lauper, S. A. Bergstra, et al. "OP0199 POINTS TO CONSIDER WHEN ANALYSING AND REPORTING COMPARATIVE EFFECTIVENESS RESEARCH WITH OBSERVATIONAL DATA IN RHEUMATOLOGY." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 124–25. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1162.
Full textAbstract:
Background:Comparing drug effectiveness in observational settings is hampered by several major threats, among them confounding and attrition bias bias (patients who stop treatment no longer contribute information, which may overestimate true drug effectiveness).Objectives:To present points to consider (PtC) when analysing and reporting comparative effectiveness with observational data in rheumatology (EULAR-funded taskforce).Methods:The task force comprises 18 experts: epidemiologists, statisticians, rheumatologists, patients, and health professionals.Results:A systematic literature review of methods currently used for comparative effectiveness research in rheumatology and a statistical simulation study were used to inform the PtC (table). Overarching principles focused on defining treatment effectiveness and promoting robust and transparent epidemiological and statistical methods increase the trustworthiness of the results.Points to considerReporting of comparative effectiveness observational studies must follow the STROBE guidelinesAuthors should prepare a statistical analysis plan in advanceTo provide a more complete picture of effectiveness, several outcomes across multiple health domains should be comparedLost to follow-up from the study sample must be reported by the exposure of interestThe proportion of patients who stop and/or change therapy over time, as well as the reasons for treatment discontinuation must be reportedCovariates should be chosen based on subject matter knowledge and model selection should be justifiedThe study baseline should be at treatment initiation and a description of how covariate measurements relate to baseline should be includedThe analysis should be based on all patients starting a treatment and not limited to patients remaining on treatment at a certain time pointWhen treatment discontinuation occurs before the time of outcome assessment, this attrition should be taken into account in the analysis.Sensitivity analyses should be undertaken to explore the influence of assumptions related to missingness, particularly in case of attritionConclusion:The increased use of real-world comparative effectiveness studies makes it imperative to reduce divergent or contradictory results due to biases. Having clear recommendations for the analysis and reporting of these studies should promote agreement of observational studies, and improve studies’ trustworthiness, which may also facilitate meta-analysis of observational data.Disclosure of Interests:Delphine Courvoisier: None declared, Kim Lauper: None declared, Sytske Anne Bergstra: None declared, Maarten de Wit Grant/research support from: Dr. de Wit reports personal fees from Ely Lilly, 2019, personal fees from Celgene, 2019, personal fees from Pfizer, 2019, personal fees from Janssen-Cilag, 2017, outside the submitted work., Consultant of: Dr. de Wit reports personal fees from Ely Lilly, 2019, personal fees from Celgene, 2019, personal fees from Pfizer, 2019, personal fees from Janssen-Cilag, 2017, outside the submitted work., Speakers bureau: Dr. de Wit reports personal fees from Ely Lilly, 2019, personal fees from Celgene, 2019, personal fees from Pfizer, 2019, personal fees from Janssen-Cilag, 2017, outside the submitted work., Bruno Fautrel Grant/research support from: AbbVie, Lilly, MSD, Pfizer, Consultant of: AbbVie, Biogen, BMS, Boehringer Ingelheim, Celgene, Lilly, Janssen, Medac MSD France, Nordic Pharma, Novartis, Pfizer, Roche, Sanofi Aventis, SOBI and UCB, Thomas Frisell: None declared, Kimme Hyrich Grant/research support from: Pfizer, UCB, BMS, Speakers bureau: Abbvie, Florenzo Iannone Consultant of: Speaker and consulting fees from AbbVie, Eli Lilly, Novartis, Pfizer, Roche, Sanofi, UCB, MSD, Speakers bureau: Speaker and consulting fees from AbbVie, Eli Lilly, Novartis, Pfizer, Roche, Sanofi, UCB, MSD, Joanna KEDRA: None declared, Pedro M Machado Consultant of: PMM: Abbvie, Celgene, Janssen, Lilly, MSD, Novartis, Pfizer, Roche and UCB, Speakers bureau: PMM: Abbvie, BMS, Lilly, MSD, Novartis, Pfizer, Roche and UCB, Lykke Midtbøll Ørnbjerg Grant/research support from: Novartis, Ziga Rotar Consultant of: Speaker and consulting fees from Abbvie, Amgen, Biogen, Eli Lilly, Medis, MSD, Novartis, Pfizer, Roche, Sanofi., Speakers bureau: Speaker and consulting fees from Abbvie, Amgen, Biogen, Eli Lilly, Medis, MSD, Novartis, Pfizer, Roche, Sanofi., Maria Jose Santos Speakers bureau: Novartis and Pfizer, Tanja Stamm Grant/research support from: AbbVie, Roche, Consultant of: AbbVie, Sanofi Genzyme, Speakers bureau: AbbVie, Roche, Sanofi, Simon Stones Consultant of: I have been a paid consultant for Envision Pharma Group and Parexel. This does not relate to this abstract., Speakers bureau: I have been a paid speaker for Actelion and Janssen. These do not relate to this abstract., Anja Strangfeld Speakers bureau: AbbVie, BMS, Pfizer, Roche, Sanofi-Aventis, Robert B.M. Landewé Consultant of: AbbVie; AstraZeneca; Bristol-Myers Squibb; Eli Lilly & Co.; Galapagos NV; Novartis; Pfizer; UCB Pharma, Axel Finckh Grant/research support from: Pfizer: Unrestricted research grant, Eli-Lilly: Unrestricted research grant, Consultant of: Sanofi, AB2BIO, Abbvie, Pfizer, MSD, Speakers bureau: Sanofi, Pfizer, Roche, Thermo Fisher Scientific
5
Tse, K., Y. Peña, K. Arntsen, et al. "AB1338-HPR GLOBAL PATIENT PERSPECTIVE ON TOP CHALLENGES IN LUPUS CARE AND RESEARCH PARTICIPATION." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 1957.1–1957. http://dx.doi.org/10.1136/annrheumdis-2020-eular.2871.
Full textAbstract:
Background:The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus initiative to identify, prioritize and address top barriers in lupus drug development, clinical care and access to care. The Lupus Foundation of America convenes ALPHA with Tufts Center for the Study of Drug Development and a Global Advisory Committee of lupus experts representing clinician-scientists, industry and patients.Objectives:Collect global patient input to determine alignment with the lupus clinician-scientist community on prior published consensus of top lupus barriers.Methods:A 23-question online Qualtrics survey was developed to identify challenges across lupus diagnosis, clinical care and research participation. The survey, available in English, Spanish, Korean and simplified Chinese, was fielded in November 2019 to people with lupus and caregivers of children <18 with lupus. SPSS 26 and SAS 9.4 were used for descriptive statistics and sub-analysis.Results:Analysis included only consented responses with ≥ 68% survey completion (n=3,447) received across 83 countries. 95% were female with a mean age of 45. Respondents reported being White (57%), Black or of African descent (14%), Hispanic or Latino (18%) and Asian (10%). 65% resided in the US while 35% resided in countries outside of the US. 97% were people with lupus while 3% were caregivers to children <18 with lupus.Highest ranked challenges were similar globally and across children and adults: medication side effects, lack of treatment options and high out-of-pocket costs. Managing side effects ranked significantly higher (p<.05) outside of the US (48%) compared to US (40%). 50% of caregivers reported managing side effects as the top challenge for children compared to 43% of adults (p<.05). Research participation was low (24%) and lower among children (16%). The top reason for not participating in a clinical trial was not being asked by their doctor.Conclusion:This global survey revealed that medication side effects and lack of effective treatments are top challenges for people with lupus, including children. Most respondents were never asked by their doctors to participate in a clinical trial, which may explain difficulties in trial recruitment. These barriers are consistent with prior published barriers identified by the clinician-scientist community.Acknowledgments:ALPHA sponsors: EMD Serono, GSK, Aurinia, MallinckrodtDisclosure of Interests:Karin Tse: None declared, Yaritza Peña: None declared, Kathleen Arntsen: None declared, Sang-Cheol Bae: None declared, Lauren Bloch Consultant of: Faegre Drinker Consulting is a division of Faegre Drinker Biddle & Reath, a law and consulting firm that represents patient advocacy organizations and sponsors developing drugs, Ian N. Bruce Grant/research support from: Genzyme Sanofi, GSK, and UCB, Consultant of: Eli Lilly, AstraZeneca, UCB, Iltoo, and Merck Serono, Speakers bureau: UCB, Karen Costenbader Grant/research support from: Merck, Consultant of: Astra-Zeneca, Bradley Dickerson Employee of: Aurinia, Thomas Dörner Grant/research support from: Janssen, Novartis, Roche, UCB, Consultant of: Abbvie, Celgene, Eli Lilly, Roche, Janssen, EMD, Speakers bureau: Eli Lilly, Roche, Samsung, Janssen, Kenneth Getz: None declared, Amy Kao Employee of: EMD Serono, Susan Manzi: None declared, Eric F. Morand Grant/research support from: AstraZeneca, Consultant of: AstraZeneca, Speakers bureau: AstraZeneca, Sandra Raymond: None declared, Brad H Rovin Grant/research support from: GSK, Consultant of: GSK, Laura Schanberg Grant/research support from: Sobi, BMS, Consultant of: Aurinia, UCB, Sanofi, Victoria Werth Grant/research support from: Biogen, Celgene, Gilead, Janssen, Viela, Consultant of: Biogen, Gilead, Janssen, Abbvie, GSK, Resolve, AstraZeneca, Amgen, Eli Lilly, EMD Serono, BMS, Viela, Kyowa Kirin, Joan Von Feldt Shareholder of: GSK, Employee of: GSK, David Zook Consultant of: Faegre Drinker Consulting is a division of Faegre Drinker Biddle & Reath, a law and consulting firm that represents patient advocacy organizations and sponsors developing drugs, Leslie Hanrahan: None declared
6
Highfield, Julie, and Jack Parry-Jones. "Professional Quality of Life in intensive care medicine: The 2018 Faculty of Intensive Care Medicine Workforce survey." Journal of the Intensive Care Society 21, no. 4 (2019): 299–304. http://dx.doi.org/10.1177/1751143719877102.
Full textAbstract:
Background Critical care is widely perceived, both within and outside of the speciality, as unremitting and emotionally burdensome. There is a perception of a higher risk to medical staff of burnout than other specialities. Critical care also has considerable emotional and professional rewards. We sought to examine this balance between emotional reward and stress in UK critical care consultants registered with the Faculty of Intensive Care Medicine. Method We conducted a Wellbeing survey of the Faculty of Intensive Care Medicine consultant membership utilising the Professional Quality of Life (Pro-QOL) survey tool. The survey was conducted as part of the Annual Workforce Census. Results In sum, 799 members completed the Pro-QOL survey, making this one of the largest surveys of physician wellbeing in critical care medicine. Data were analysed in accordance with the Pro-QOL manual. Conclusions The results demonstrate moderate risk for burnout and secondary traumatic stress, but this is balanced by moderate compassion satisfaction. No association was demonstrated between age, sex, or size of critical care unit worked in. Further follow-up of this consultant group is warranted to better understand risk factors for burnout and for future mitigation of these risk factors whilst also enhancing the positive aspects of working as a consultant in critical care medicine.
7
Spiers, H., H. Enayati, R. Moussa, et al. "Augmenting ENT surgery outside the medical school curriculum: the role of a 1-day otolaryngology course." Journal of Laryngology & Otology 133, no. 4 (2019): 269–74. http://dx.doi.org/10.1017/s0022215119000331.
Full textAbstract:
AbstractBackgroundENT is highly under-represented in the saturated UK medical school curriculum, comprising less than 1 per cent of the curriculum. A 1-day course was implemented in order to raise awareness of ENT among medical students, educate them in the specialty and teach a basic skill.MethodsThe skills day comprised lectures by consultants followed by a consultant-led workshop teaching tracheostomy. Pre- and post-course questionnaires assessed perceptions of ENT, confidence performing tracheostomy and interest in ENT as a career.ResultsPerceptions of ENT as a specialty were improved by up to 80 per cent (p < 0.01). There was improved understanding of and confidence in performing tracheostomies. Interest in a career in ENT was increased by 77 per cent (p < 0.01).ConclusionA 1-day course run by a student body can be a powerful adjunct to the medical school curriculum, in terms of educating undergraduates in ENT and inspiring the pursuit of ENT as a career.
8
Lauper, K., J. Kedra, M. De Wit, et al. "OP0198 A SYSTEMATIC REVIEW TO INFORM THE EULAR POINTS TO CONSIDER WHEN ANALYSING AND REPORTING COMPARATIVE EFFECTIVENESS RESEARCH WITH OBSERVATIONAL DATA IN RHEUMATOLOGY." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 123.2–124. http://dx.doi.org/10.1136/annrheumdis-2020-eular.882.
Full textAbstract:
Background:Comparative effectiveness studies using observational data are increasingly used. Despite their high potential for bias, there are no detailed recommendations on how these studies should best be analysed and reported in rheumatology.Objectives:To conduct a systematic literature review of comparative effectiveness research in rheumatology to inform the EULAR task force developing points to consider when analysing and reporting comparative effectiveness research with observational data.Methods:All original articles comparing drug effectiveness in longitudinal observational studies of ≥100 patients published in key rheumatology journals (Scientific Citation Index > 2) between 1.01.2008 and 25.03.2019 available in Ovid MEDLINE® were included. Titles and abstracts were screened by two reviewers for the first 1000 abstracts and independently checked to ensure sufficient agreement has been reached. The main information extracted included the types of outcomes used to assess effectiveness, and the types of analyses performed, focusing particularly on confounding and attrition.Results:9969 abstracts were screened, with 218 articles proceeding to full-text extraction (Figure 1), representing a number of rheumatic and musculoskeletal diseases. Agreement between the two reviewers for the first 1000 abstracts was 92.7% with a kappa of 0.6. The majority of the studies used several outcomes to evaluate effectiveness (Figure 2A). Most of the studies did not explain how they addressed missing data on the covariates (70%) (Figure 2B). When addressed (30%), 44% used complete case analysis and 10% last observation carried forward (LOCF). 25% of studies did not adjust for confounding factors and there was no clear correlation between the number of factors used to adjust and the number of participants in the studies. An important number of studies selected covariates using bivariate screening and/or stepwise selection. 86% of the studies did not acknowledge attrition (Figure 2C). When trying to correct for attrition (14%), 38% used non-responder (NR) imputation, 24% used LUNDEX1, a form of NR imputation, and 21% LOCF.Conclusion:Most of studies used multiple outcomes. However, the vast majority did not acknowledge missing data and attrition, and a quarter did not adjust for any confounding factors. Moreover, when attempting to account for attrition, several studies used methods which potentially increase bias (LOCF, complete case analysis, bivariate screening…). This systematic review confirms the need for the development of recommendations for the assessment and reporting of comparative drug effectiveness in observational data in rheumatology.References:[1]Kristensen et al. A&R. 2006 Feb;54(2):600-6.Acknowledgments:Support of the Standing Committee on Epidemiology and Health Services ResearchDisclosure of Interests:Kim Lauper: None declared, Joanna KEDRA: None declared, Maarten de Wit Grant/research support from: Dr. de Wit reports personal fees from Ely Lilly, 2019, personal fees from Celgene, 2019, personal fees from Pfizer, 2019, personal fees from Janssen-Cilag, 2017, outside the submitted work., Consultant of: Dr. de Wit reports personal fees from Ely Lilly, 2019, personal fees from Celgene, 2019, personal fees from Pfizer, 2019, personal fees from Janssen-Cilag, 2017, outside the submitted work., Speakers bureau: Dr. de Wit reports personal fees from Ely Lilly, 2019, personal fees from Celgene, 2019, personal fees from Pfizer, 2019, personal fees from Janssen-Cilag, 2017, outside the submitted work., Bruno Fautrel Grant/research support from: AbbVie, Lilly, MSD, Pfizer, Consultant of: AbbVie, Biogen, BMS, Boehringer Ingelheim, Celgene, Lilly, Janssen, Medac MSD France, Nordic Pharma, Novartis, Pfizer, Roche, Sanofi Aventis, SOBI and UCB, Thomas Frisell: None declared, Kimme Hyrich Grant/research support from: Pfizer, UCB, BMS, Speakers bureau: Abbvie, Florenzo Iannone Consultant of: Speaker and consulting fees from AbbVie, Eli Lilly, Novartis, Pfizer, Roche, Sanofi, UCB, MSD, Speakers bureau: Speaker and consulting fees from AbbVie, Eli Lilly, Novartis, Pfizer, Roche, Sanofi, UCB, MSD, Pedro M Machado Consultant of: PMM: Abbvie, Celgene, Janssen, Lilly, MSD, Novartis, Pfizer, Roche and UCB, Speakers bureau: PMM: Abbvie, BMS, Lilly, MSD, Novartis, Pfizer, Roche and UCB, Lykke Midtbøll Ørnbjerg Grant/research support from: Novartis, Ziga Rotar Consultant of: Speaker and consulting fees from Abbvie, Amgen, Biogen, Eli Lilly, Medis, MSD, Novartis, Pfizer, Roche, Sanofi., Speakers bureau: Speaker and consulting fees from Abbvie, Amgen, Biogen, Eli Lilly, Medis, MSD, Novartis, Pfizer, Roche, Sanofi., Maria Jose Santos Speakers bureau: Novartis and Pfizer, Tanja Stamm Grant/research support from: AbbVie, Roche, Consultant of: AbbVie, Sanofi Genzyme, Speakers bureau: AbbVie, Roche, Sanofi, Simon Stones Consultant of: I have been a paid consultant for Envision Pharma Group and Parexel. This does not relate to this abstract., Speakers bureau: I have been a paid speaker for Actelion and Janssen. These do not relate to this abstract., Anja Strangfeld Speakers bureau: AbbVie, BMS, Pfizer, Roche, Sanofi-Aventis, Robert B.M. Landewé Consultant of: AbbVie; AstraZeneca; Bristol-Myers Squibb; Eli Lilly & Co.; Galapagos NV; Novartis; Pfizer; UCB Pharma, Axel Finckh Grant/research support from: Pfizer: Unrestricted research grant, Eli-Lilly: Unrestricted research grant, Consultant of: Sanofi, AB2BIO, Abbvie, Pfizer, MSD, Speakers bureau: Sanofi, Pfizer, Roche, Thermo Fisher Scientific, Sytske Anne Bergstra: None declared, Delphine Courvoisier: None declared
9
von Platen, Sara. "The communication consultant: an important translator for communication management." Journal of Communication Management 19, no. 2 (2015): 150–66. http://dx.doi.org/10.1108/jcom-06-2013-0049.
Full textAbstract:
Purpose – The purpose of this paper is to put forward a theoretical model which conceptualizes and clarifies the function and skills of communication consultants in terms of translation. Design/methodology/approach – The paper combines theoretical underpinnings from Scandinavian institutional theory with empirical examples from an interview study with ten senior communication managers in Swedish public sector organizations. Findings – Communication consultants are explained to perform varying translator functions ranging from a neutral transcoder to a freely interpretive translator and sensegiver. These functions are enacted as the consultant span organizational boundaries and contexts inside and outside the organization. The consultants are apt to carry out these tasks due to their translator expertise which resides in, e.g. multicontextual knowledge and bilingual skills, something which their clients lack. Research limitations/implications – The scope of the empirical material is limited to public organizations and a Swedish setting, and may therefore not be valid in other cultural contexts. Practical implications – The model highlights the intersecting work of communication consultants and their clients and thus raises questions concerning the legitimacy and core responsibilities of communication managers. The paper also argues that managers and consultants need to develop their translator skills, and that higher education in communication and PR should prepare students for professions where translator skills may be of great importance. Originality/value – The functions and tasks of communication consultants is a neglected area in communication research. By providing a comprehensive and pragmatic framework for communication consultants work as translation, the present research adds knowledge about the essential functions these actors perform and how they contribute to communication management as well as to organizational performance.
10
Vaughan, Phillip J. "The supervision register: one year on." Psychiatric Bulletin 20, no. 3 (1996): 143–45. http://dx.doi.org/10.1192/pb.20.3.143.
Full textAbstract:
A postal survey was conducted within four regional Health Authorities to ascertain how widely the supervision register had been applied in its first year of operation in adult mental health. A 72% response rate was achieved. The results showed that the register has been absorbed organisationally but is less accepted professionally. One hundred and nineteen of the 367 consultants in the sample (32%) had no entries on the register at 31st March 1995. The provision of training on its use had a significant effect on compliance, although London-based services had marginally less registrations per consultant than their colleagues elsewhere. Very few outside agencies had required access to the register.
Dissertations / Theses on the topic "Outside consultant"
1
Boyle, Bettina Helth Arnum. "Online Tables & Tablecloths: Facilitating Space for Online Learning & Collaboration." Thesis, 2009. http://hdl.handle.net/1807/18115.
Full textAbstract:
This thesis describes the researcher’s journey as an online facilitator and reflective organization development (OD) practitioner as she explores how to nurture and cultivate space for learning and collaboration in an online community of practice. The research setting is a small group of mostly volunteers in a national health charity. The researcher adopts a reflective practitioner research approach engaging in a continuous process of story-telling throughout the thesis. She struggles with questions such as her own dynamic role as an outside facilitator, the role of technology, dilemmas of emergence versus design and discovery of purpose. Rather than arriving at a to-do-list for potential online facilitators, she discovers that hosting café style conversations, setting the online tables and enabling space for learning, collaboration and aliveness is more a matter of the facilitator’s capacity to listen, to be authentically present and to relinquish control.
Books on the topic "Outside consultant"
1
The executive's guide to consultants: How to find, hire and get great results from outside experts. McGraw-Hill, 2013.
Find full text
2
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. NIH ethics concerns: Consulting arrangements and outside awards : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, May 12, May 18, and June 22, 2004. U.S. G.P.O., 2004.
Find full text
3
Kara, Helen, and Paul Muir. Commissioning Consultancy: Managing Outside Expertise to Improve Your Services. Russell House Publishing Limited, 2003.
Find full text
4
author, Smallwood W. Norman, ed. Agile talent: How to source and manage outside experts. Harvard Business Review Press, 2016.
Find full text
5
American Institute of Certified Public Accountants. Management Consulting Services Division., ed. Assisting clients to establish an outside advisory board. American Institute of Certified Public Accountants, Management Consulting Services Division, 1993.
Find full text
6
National Institutes of Health (U.S.), ed. The need for and management of human tissue for research purposes: Report of a concept review by outside consultants to the NIH. National Institutes of Health, 1988.
Find full text
7
Baron, Alan, John Hassard, Fiona Cheetham, and Sudi Sharifi. Images of the Hospice. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198813958.003.0009.
Full textAbstract:
This chapter looks ‘outside’ the Hospice at issues of the organization’s image. The authors talked to staff, volunteers, and members of the general public, as well as to a number of key stakeholders in the local healthcare community, in order to gauge their views on the host organization. The analysis examines the problems associated with the image of hospices and discusses attempts of staff and volunteers to ‘dispel the myths’ about the nature of hospice care work—a form of labour which potentially runs the risk of being characterized as ‘dirty work’. The chapter then examines how the Hospice is seen in the eyes of other healthcare professionals and discusses the choice of palliative medicine as a career for junior medics. Finally it discusses a degree of ‘confusion’ that staff and volunteers claim exists in the minds of GPs and consultants in specialist cancer hospitals about the role of hospices.
8
Walfish, Steven, Jeffrey E. Barnett, and Jeffrey Zimmerman, eds. Handbook of Private Practice. Oxford University Press, 2017. http://dx.doi.org/10.1093/med:psych/9780190272166.001.0001.
Full textAbstract:
Running a professional practice is an exciting, daunting, and at times frustrating endeavor. The goal of this book is to provide you with the practical information and guidance you will need to be successful in private practice. The first part of this book begins by addressing essential concepts related to beginning in practice, managing your practice, and using practice management consultants. It goes on to discuss the business of practice, growing a practice, building collaborative relationships to aid in growing your practice, and addressing common ethical and legal issues relevant to starting, running, and closing a private practice. This section concludes with a discussion of a range of special issues related to private practice that should assist you to develop, maintain, and grow a successful private practice. There are plenty of opportunities for learning a great deal about how to take the concept of being in practice and turning it into a business. The second section of this book contains chapters describing niche practice areas, written by private practitioners who actually are providing the services. Each of these short chapters provides brief, readable descriptions of assessment practices, psychotherapy practices, and other unique uses of mental health professionals’ skillsets that are applied outside of the more traditional medical model. This book is intended to help you develop a practice environment that allows you to support yourself and your loved ones while you provide the best care possible to those you serve.
9
Dean, James W., and Deborah Y. Clarke. The Insider's Guide to Working with Universities. University of North Carolina Press, 2019. http://dx.doi.org/10.5149/northcarolina/9781469653419.001.0001.
Full textAbstract:
Colleges and universities stand to benefit greatly when businesspeople engage with them, whether through governing boards, alumni associations, consulting arrangements, philanthropy, or other channels. But many businesspeople are frustrated by the way institutions of higher education work--or rather, how they don't work. Why do decisions in universities take so long and involve so many people? Why aren't profit and growth top priorities for colleges? Why can't the faculty be managed like any other employees? Shouldn't alumni have a greater say as they continue to invest in their alma mater? As leaders in higher education, James W. Dean Jr. and Deborah Y. Clarke have years of experience addressing these questions for a wide range of professionals outside the academy. This book draws on their expertise to offer real-world guidance for businesspeople who work with and seek to improve colleges and universities. Dean and Clarke differentiate and clarify the motivations and structures that make universities unique among American enterprises. And while they acknowledge the challenges that businesspeople often face when working with academic institutions, they explain that understanding the distinct mission of higher education is essential to being able to effect change within these organizations. Presenting insights from interviews with a wide range of stakeholders, Dean and Clarke give succinct and practical advice for working with universities.
10
Hutson, Mike. Assessment and management. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199533909.003.0011.
Full textAbstract:
Individuals undertaking exercise include those engaged in aerobic activities as part of a healthy lifestyle, those engaged in an active fitness or rehabilitation programme relevant to acute or chronic conditions such as cardiovascular disease, respiratory problems, and musculoskeletal disorders, and the committed competitive athlete with high performance targets. Accordingly, those injured as a consequence of exercise or sport attend medical practitioners in diverse circumstances. Urgency of assessment of the full impact of injury clearly varies across the spectrum from the life-threatening situation on the field of play (or other sports/recreational exercise location, for instance poolside or roadside) to one in which a chronic condition can be evaluated in the relative comfort of the clinician’s consulting room. Irrespective of the circumstances, the primary requirement is the establishment of an accurate diagnosis. The process of assessment is aided when relevant by an appropriate index of suspicion with respect to those injuries that are not often seen outside sporting and recreational activity (e.g. throwers’ elbow and shin splints). Diagnosis of tissue injury is followed by a full assessment of its impact on the function of the surrounding structures, and subsequently assessment of impairment of sporting capacity in general. Evaluation is made of the aetiological factors associated with the development of injury, the behavioural responses, including motivation and health prioritization, and the individual’s standard of performance (actual and potential). Clinical assessment (and reassessment) is a constant theme throughout the text....
Book chapters on the topic "Outside consultant"
1
Bascomb, Cheryl. "The Outside Consultant." In Bull's-Eye! The Ultimate How-To Marketing & Sales Guide for CPAs. John Wiley & Sons, Inc., 2017. http://dx.doi.org/10.1002/9781119448679.ch13.
Full text
2
Solomon, Robin. "The professional couple, the consultant, and the outside world." In A For Adoption. Routledge, 2020. http://dx.doi.org/10.4324/9781003006633-6.
Full text
3
Gunter, Helen M., and Colin Mills. "Researchers as Consultants in and outside of Universities." In Consultants and Consultancy: the Case of Education. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-48879-0_3.
Full text
4
Gunter, Helen M., and Colin Mills. "Professionals as Consultants in and outside of Companies." In Consultants and Consultancy: the Case of Education. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-48879-0_4.
Full text
5
Papadopoulos, Renos K. "Therapeutic Encounters and Interventions Outside the Consulting Room." In Analysis and Activism. Routledge, 2016. http://dx.doi.org/10.4324/9781315669700-2.
Full text
6
Klontz, Brad. "Consulting with financial planners." In Earning a living outside of managed mental health care: 50 ways to expand your practice. American Psychological Association, 2010. http://dx.doi.org/10.1037/12138-030.
Full text
7
Nigam, Amit, Esther Sackett, and Brian Golden. "The Role of Outside Consultants in Shaping Hospital Organizational Change." In Managing Change. Palgrave Macmillan UK, 2015. http://dx.doi.org/10.1057/9781137518163_9.
Full text
8
Shea, Kathleen V. "Consulting to family-owned businesses." In Earning a living outside of managed mental health care: 50 ways to expand your practice. American Psychological Association, 2010. http://dx.doi.org/10.1037/12138-020.
Full text
9
Wise, Edward A. "Consulting with health care organizations." In Earning a living outside of managed mental health care: 50 ways to expand your practice. American Psychological Association, 2010. http://dx.doi.org/10.1037/12138-028.
Full text
10
Houpt, Jeffrey L., Roderick W. Gilkey, and Susan H. Ehringhaus. "Strategic Planning/Outside Consultants: Power and Authority, Vertical Hierarchies, and the Informal Organization." In Learning to Lead in the Academic Medical Center. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-21260-9_16.
Full textConference papers on the topic "Outside consultant"
1
Moon, Sungrim, Sijia Liu, Paul Kingsbury, et al. "Medical concept intersection between outside medical records and consultant notes: A case study in transferred cardiovascular patients." In 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2017. http://dx.doi.org/10.1109/bibm.2017.8217883.
Full text
2
Grzyb, David W., and Michael F. Hallihan. "Study of High Vapour Pressure Pipeline Safety." In 2002 4th International Pipeline Conference. ASMEDC, 2002. http://dx.doi.org/10.1115/ipc2002-27375.
Full textAbstract:
The Alberta Energy and Utilities Board (EUB) recently initiated a study to examine and evaluate whether existing regulations and standards adequately ensure the safe operation of High Vapour Pressure (HVP) pipelines in Alberta. An engineering consultant was contracted to review the performance history of HVP pipelines, determine the predominant failure modes and causes, compare Alberta performance against other jurisdictions, and provide a report containing recommendations for improvements. The consultant concluded that the predominant cause of HVP pipeline failures has been interference from outside parties, followed equally by material deficiencies and corrosion. The report also concluded that HVP pipelines in Alberta have been operating at a failure frequency approximately 30 per cent less than the failure frequency of hazardous liquids pipelines in the United States. The paper first provides a brief description of the role of the EUB in Alberta, followed by a summary of HVP pipeline performance. A description of the methodology used to conduct the study follows, along with the conclusions and recommendations made by the consultant. A process for the verification of the proposed changes by the affected stakeholders is then described, followed finally by a description of how any proposed regulatory changes may be completed.
3
Greenwood, Sarah, and Helen Higgs. "Developing Satisfied and Talented Consultants." In The 11th International Conference on Environmental Remediation and Radioactive Waste Management. ASMEDC, 2007. http://dx.doi.org/10.1115/icem2007-7347.
Full textAbstract:
It has been well documented that the ageing, male dominated profile of the workforce in the UK nuclear industry will not support the forecasted nuclear renaissance. Based upon the aspects of age, gender and level of education, there is an existing shortfall in available knowledgeable resource to undertake and manage the extensive new build, operational and decommissioning programmes. The 2005 Nuclear Employers Survey advised the industry to recruit and train more: • young and qualified people. • experienced and qualified people from outside the industry. The future for the UK nuclear industry lies with people in their 20s and 30s. It is essential that not just technical talent but also managerial talent be identified early and that they are nourished and allowed to flourish.
4
Lucas, William C., and George F. Hessler. "The Reduction of Low Frequency Gas Turbine Exhaust Noise: A Case Study." In ASME 1996 International Gas Turbine and Aeroengine Congress and Exhibition. American Society of Mechanical Engineers, 1996. http://dx.doi.org/10.1115/96-gt-010.
Full textAbstract:
A well reported, industry-wide problem with simple cycle peaking gas turbines installed near residences is excessive low frequency airborne noise, sometimes termed “infrasound.” If the noise level is high enough, it can cause perceptible vibration of windows and frame buildings, and provoke an adverse response from the community. Such a situation recently occurred after construction of a four unit GT 11N1 peaking station. A team of specialists and outside consultants was formed to investigate the problem, and a development program found that a thick absorber could be effective against infrasound. This led to the design of a thick panel absorber which was installed at the rear of a 90 degree turn in the exhaust system. Field testing verified that the low frequency noise from the turbine exhaust was reduced by 5.9 and 6.7 dB in the 31.5 and 63 Hz octave bands respectively, and by 5.5 dB(C) overall.
5
Parr, Corhyn. "Collaborative ReTek Exchange: An Innovative Solution to the Skills and Resource Shortage in the Nuclear Industry." In ASME 2009 12th International Conference on Environmental Remediation and Radioactive Waste Management. ASMEDC, 2009. http://dx.doi.org/10.1115/icem2009-16396.
Full textAbstract:
A Different Approach to the Skills and Resource Shortage The Nuclear Industry has for many years been concerned about a skills and resource shortage. This has been due to a poor perception of the industry by those on the outside, highly competitive industries vying for the same resource pool, a steep retirement curve for highly qualified staff and a lack of graduates entering industry. Here in the UK the creation of the National Skill Academy for Nuclear (NSAN) has put in place a framework to record skills and look to accredit the training providers in the nuclear industry to ensure that the correct skills for the future are available. This has gone some way to solving the skills problem and developing a well recognised accredited system but what about resource — where are the additional qualified resources going to be found? Part of the Solution – A Resource Exchange. How do we solve the skills shortage? We come together as an industry and share the available resource through a collaborative resource exchange. It has been done before in the IT industry when rates for specialists hit £1500 per day and recruitment agencies were charging extortionate fees for providing temporary resource. ReTek Consulting have developed the ReTek Resource Exchange to provide a neutral collaborative platform across the supply chain; from large scale infrastructure companies and joint venture platforms through to small companies and independent consultants. Using the ReTek Exchange permanent staff are made available to work for others during periods of underutilisation. Links with similar highly regulated industries enable further management of peaks and troughs and a growth in experienced nuclear professionals through focused training and development. The Benefits of the ReTek Exchange are: • Increased utilisation of your current workforce. • Shared cost of permanent staff. • Speedy access to staff available in your region. • Reduced need for contract or agency staff. • Access to wider skills & experience. • Retention of key staff through personal development. • Knowledge and experience transfer. Now is the time in the industry to make the most of the available resource and work together to ensure the required growth through training and development of all workers. The infrastructure required to make this resource exchange possible is available and proven many times. This paper will talk through the story of the development of the ReTek Exchange in the UK and how the same system can be used elsewhere in the world.
6
Smith-Briggs, Jane, Dave Wells, Tommy Green, Andy Baker, Martin Kelly, and Richard Cummings. "The Australian National Radioactive Waste Repository: Environmental Impact Statement and Radiological Risk Assessment." In ASME 2003 9th International Conference on Radioactive Waste Management and Environmental Remediation. ASMEDC, 2003. http://dx.doi.org/10.1115/icem2003-4865.
Full textAbstract:
The Environmental Impact Statement (EIS) for the proposed Australian National Repository for low and short-lived intermediate level radioactive waste was submitted to Environment Australia for approval in the summer of 2002 and has subsequently undergone a consultancy phase with comments sought from all relevant stakeholders. The consultancy period is now closed and responses to the comments have been prepared. This paper describes some of the issues relevant to determining the radiological risk associated with the repository to meet the requirements of the EIS. These include a brief description of the three proposed sites, a description of the proposed trench design, an analysis of the radioactive waste inventory, the proposed approach to developing waste acceptance criteria (WAC) and the approach taken to determine radiological risks during the post-institutional control phase. The three potential sites for the repository are located near the Australian Department of Defence site at Woomera, South Australia. One site is inside the Defense site and two are located nearby, but outside of the site perimeter. All have very similar, but not identical, topographical, geological and hydrogeological characteristics. A very simple trench design has been proposed 15 m deep and with 5 m of cover. One possible variant may be the construction of deeper borehole type vaults to dispose of the more active radioactive sources. A breakdown of the current and predicted future inventory will be presented. The current wastes are dominated in terms of volume by some contaminated soils, resulting from experiments to extract U and Th, and by the operational wastes from the HIFAR research reactor at ANSTO. A significant proportion of the radionuclide inventory is associated with small volumes of sources held by industry, medical, research and defence organisations. The proposed WAC will be described. These are based on the current Australian guidelines and best international practice. The preliminary radiological risk assessment considered the post-institutional control phase in detail with some 12 scenarios being assessed. These include the impact of potential climate change in the region. The results from the risk assessment will be presented and discussed. The assessment work is continuing and will support the license application for construction and operation of the site. Please note that this is not the final assessment for the licence application.
7
Geddes, Brian, Chris Wenzel, Michael Owen, Mark Gardiner, and Julie Brown. "Remediation of Canada’s Historic Haul Route for Radium and Uranium Ores: The Northern Transportation Route." In ASME 2011 14th International Conference on Environmental Remediation and Radioactive Waste Management. ASMEDC, 2011. http://dx.doi.org/10.1115/icem2011-59303.
Full textAbstract:
Established in the 1930s, the Northern Transportation Route (NTR) served to transport pitchblende ore 2,200 km from the Port Radium Mine in Canada’s Northwest Territories to Fort McMurray in Alberta. From there, the ore was shipped 3,000 km by rail to the Town of Port Hope, Ontario, where it was refined for its radium content and used for medical purposes. Later, transport and refinement focussed on uranium. The corridor of lakes, rivers, portages and roads that made up the NTR included a number of transfer points, where ore was unloaded and transferred to other barges or trucks. Ore was occasionally spilled during these transfer operations and, in some cases, subsequently distributed over larger areas as properties were re-developed or modified. In addition, relatively small volumes of ore were sometimes transported by air to the south. Since 1991, the Low-Level Radioactive Waste Management Office (LLRWMO), working with communities and its consulting contractors, has conducted surveys to identify and characterize spill sites along the NTR where soils exhibit elevated concentrations of uranium, radium and/or arsenic. In addition to significant areas of impact in Fort McMurray, contamination along the NTR was centred in the Sahtu region near Great Bear Lake and along the southern part of the Slave River. Early radiological investigations found contaminated buildings and soil and occasionally discrete pieces of pitchblende ore at many transfer points and storage areas along the NTR. Where possible, survey work was undertaken in conjunction with property redevelopment activity requiring the relocation of impacted soils (e.g., at Tulita, Fort Smith, Hay River, and Fort McMurray). When feasible to consolidate contaminated material locally, it was placed into Long Term Management Facilities developed to manage and monitor the materials over extended timelines. Radiological activity generated by these engineered facilities are generally below thresholds established by Canadian regulators, meaning they are straightforward to maintain, with minor environmental and community impacts. Securing community acceptance for these facilities is critical, and represents the predominant development component of plans for managing ore-impacted soils. In those circumstances where local consolidation is not achievable, materials have been relocated to disposal facilities outside of the region. The LLRWMO is continuing a program of public consultation, technical evaluation and environmental assessment to develop management plans for the remaining ore-impacted sites on the NTR. This paper will highlight current activities and approaches applied for the responsible management of uranium and radium mining legacies.